🔎 Trials Near Me

Hjem › Depresjon › Arkansas

Kliniske studier for Depresjon i Arkansas

10 studier for Depresjon søker deltakere på steder i Arkansas.

Byer i Arkansas

Offisiell studietekst (engelsk)

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)

  • Pillar Clinical Research, Bentonville
  • SanRo Clinical Research Group, Bryant
RekruttererFase 3
Alder 18 til 74 · Alle kjønn · Oppdatert 8. sep. 2026 · NCT07076407

A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

  • Draig Clinical Site, Little Rock
RekruttererFase 2
Alder 18 til 75 · Alle kjønn · Oppdatert 2. sep. 2026 · NCT07610473

A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

  • Draig Clinical Site, Bentonville
  • Draig Clinical Site, Little Rock
RekruttererFase 2
Alder 18 til 75 · Alle kjønn · Oppdatert 26. aug. 2026 · NCT07300969

NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  • Neurocrine Clinical Site, Bryant
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 11. aug. 2026 · NCT06911112

E-Mindfulness Approaches for Living After Breast Cancer

  • Mercy Hospital Fort Smith, Fort Smith
  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro
  • University of Arkansas for Medical Sciences, Little Rock
RekruttererFase 3
Alder 18 til 50 · Alle kjønn · Oppdatert 4. aug. 2026 · NCT06748222

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

  • Woodland International Research Group, Little Rock
  • Woodland Research Northwest, Rogers
RekruttererFase 3
Alder 18 til 74 · Alle kjønn · Oppdatert 3. aug. 2026 · NCT06775379

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  • Neurocrine Clinical Site, Bryant
  • Neurocrine Clinical Site, Little Rock
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 24. jul. 2026 · NCT06966401

A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

  • Pillar Clinical Research, LLC, Little Rock
  • Preferred Research Partners, Inc., Little Rock
  • Woodland Research Northwest, Rogers
RekruttererFase 2
Alder 18 til 65 · Alle kjønn · Oppdatert 11. mai 2026 · NCT06524830

Effectiveness, Implementation, and Cost of Cognitive Processing Therapy in Prisons

  • University of Arkansas for Medical Sciences, Little Rock
  • Northeast Arkansas Community Corrections Center (NEACC), Osceola
  • Southwest Arkansas Community Correction Center, Texarkana
  • og 1 flere
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 21. jan. 2026 · NCT06923423

Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  • Neurocrine Clinical Site, Little Rock
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 29. okt. 2025 · NCT06786624

Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.